Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184:1469–85.

Article  CAS  PubMed  Google Scholar 

Ödling M, Andersson N, Ekström S, Melén E, Bergström A, Kull I. Characterization of asthma in the adolescent population. Allergy. 2018;73:1744–6.

Article  PubMed  Google Scholar 

Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16:45–56.

Article  CAS  PubMed  Google Scholar 

Komlósi ZI, van de Veen W, Kovács N, Szűcs G, Sokolowska M, O'Mahony L, et al. Cellular and molecular mechanisms of allergic asthma. Mol Asp Med. 2022;85:100995.

Article  Google Scholar 

Rodriguez-Rodriguez N, Gogoi M, McKenzie ANJ. Group 2 Innate Lymphoid Cells: Team Players in Regulating Asthma. Annu Rev Immunol. 2021;39:167–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammad H, Lambrecht BN. Barrier Epithelial Cells and the Control of Type 2 Immunity. Immunity. 2015;43:29–40.

Article  CAS  PubMed  Google Scholar 

Hellings PW, Steelant B. Epithelial barriers in allergy and asthma. J Allergy Clin Immunol. 2020;145:1499–509.

Article  PubMed  PubMed Central  Google Scholar 

Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front Immunol. 2020;11:761.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bønnelykke K, Sleiman P, Nielsen K, Kreiner-Møller E, Mercader JM, Belgrave D, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 2014;46:51–55.

Article  PubMed  Google Scholar 

Grotenboer NS, Ketelaar ME, Koppelman GH, Nawijn MC. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol. 2013;131:856–65.

Article  CAS  PubMed  Google Scholar 

Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl J Med. 2010;363:1211–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 2014;134:170–7.

Article  CAS  PubMed  Google Scholar 

Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676–89.

Article  CAS  PubMed  Google Scholar 

Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol (Baltim, Md : 1950). 2008;180:2443–9.

Article  CAS  Google Scholar 

Calise J, Garabatos N, Bajzik V, Farrington M, Robinson D, Jeong D, et al. Optimal human pathogenic T(H)2 cell effector function requires local epithelial cytokine signaling. J Allergy Clin Immunol. 2021;148:867–75.e864.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong H, Liao S, Chen F, Yang Q, Wang DY. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75:2794–804.

Article  CAS  PubMed  Google Scholar 

Hoshino K, Kashiwamura S, Kuribayashi K, Kodama T, Tsujimura T, Nakanishi K, et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med. 1999;190:1541–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA. 2010;107:18581–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saluzzo S, Gorki AD, Rana B, Martins R, Scanlon S, Starkl P, et al. First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment. Cell Rep. 2017;18:1893–905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebina-Shibuya R, Leonard WJ. Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol. 2023;23:24–37.

Article  CAS  PubMed  Google Scholar 

Leyva-Castillo JM, Hener P, Michea P, Karasuyama H, Chan S, Soumelis V, Li M. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun. 2013;4:2847.

Article  PubMed  Google Scholar 

Toki S, Goleniewska K, Zhang J, Zhou W, Newcomb DC, Zhou B, et al. TSLP and IL-33 reciprocally promote each other’s lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation. Allergy. 2020;75:1606–17.

Article  CAS  PubMed  Google Scholar 

Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. IL-25 (IL-17E) in epithelial immunology and pathophysiology. J Allergy Clin Immunol. 2021;148:40–52.

Article  CAS  PubMed  Google Scholar 

Gregory LG, Jones CP, Walker SA, Sawant D, Gowers KH, Campbell GA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax. 2013;68:82–90.

Article  PubMed  Google Scholar 

Lambrecht BN, Hammad H, Fahy JV. The Cytokines of Asthma. Immunity. 2019;50:975–91.

Article  CAS  PubMed  Google Scholar 

Calderon AA et al. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Resp Rev: Off J Eur Resp Soc. 2023;32:220144.

Porsbjerg CM, Sverrild A, Lloyd CM, Menzies-Gow AN, Bel EH Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics. Eur Resp J. 2020;56:2000260.

Salter B, Lacy P, Mukherjee M. Biologics in Asthma: A Molecular Perspective to Precision Medicine. Front Pharmacol. 2021;12:793409.

Article  CAS  PubMed  Google Scholar 

Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, et al. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. Respiratory Med. 2021;9:1299–312.

CAS  Google Scholar 

Ishizuka T, Menzies-Gow A, Okada H, Fukushima Y, Hayashi N, Colice G, et al. Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study. Allergol Int. 2023;72:82–88.

Article  CAS  PubMed  Google Scholar 

Kosloski MP, Kalliolias GD, Xu CR, Harel S, Lai CH, Zheng W, et al. Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials. Clin Transl Sci. 2022;15:384–95.

Article  CAS  PubMed  Google Scholar 

Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. N. Engl J Med. 2021;385:1656–68.

Article  CAS  PubMed  Google Scholar 

Kelsen SG, Agache IO, Soong W, Israel E, Chupp GL, Cheung DS, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021;148:790–8.

Article